Sovenyr
Subscribe
Signal
2026-07-27
ClinicalTrials.gov
[NA] Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Part of
Innovative Obesity And Metabolic Therapies
Open primary source
Read on Substack